Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
about
Role of EZH2 histone methyltrasferase in melanoma progression and metastasisLoss of the chromatin modifier Kdm2aa causes BrafV600E-independent spontaneous melanoma in zebrafish.Metal-dependent Deacetylases: Cancer and Epigenetic RegulatorsInhibition of histone deacetylases in melanoma-a perspective from bench to bedside.Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy.Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.Valproic Acid Exposure of Pregnant Rats During Organogenesis Disturbs Pancreas Development in Insulin Synthesis and Secretion of the Offspring.Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A
P2860
Q37187733-73E70B7F-0182-41B3-97EB-4227490FFEFBQ38625634-F7CFFB69-C91A-4BE2-881D-E56BD19A91F7Q38747135-9F2E4AD9-041D-45E1-BB94-52B84BDEB41CQ38993736-CC35DFF6-A4D8-474E-B0BD-D9ADDBC4FDAEQ47145423-3818A5AE-CE71-4E73-8890-7BA906C1185FQ52688134-AA9808AB-2A3B-4156-9E99-E511B361C31BQ52717197-48027039-FEB3-4592-8145-84C45330BE37Q54978342-17C714AB-6F46-4D42-9CC8-87290E055FE1Q58766034-0AC501D0-B3C6-4FCE-95FC-945C1A1FFFD4
P2860
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@ast
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@en
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@nl
type
label
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@ast
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@en
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@nl
prefLabel
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@ast
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@en
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@nl
P2860
P356
P1433
P1476
Histone Modifications, Modifie ...... to Targeted and Immune Therapy
@en
P2093
Jessamy C Tiffen
Peter Hersey
P2860
P304
P356
10.3390/CANCERS7040870
P407
P577
2015-09-25T00:00:00Z